Pharmacologic modelling of Alzheimer's disease
Pharmacologic modelling of Alzheimer's disease
复制标题
阿尔茨海默病的药理学模型
DOI:
10.1016/0278-5846(86)90030-8
复制
发表时间:
1986
影响因子:
5.6
通讯作者:
R. Cohen
中科院分区:
文献类型:
--
作者:
T. Sunderland;P. Tariot;H. Weingartner;D. Murphy;P. Newhouse;E. Mueller;R. Cohen
Abstract Sunderland, Trey, Pierre N. Tariot, Herbert Weingartner, Dennis L. Murphy, Paul A. Newhouse, Edward A. Mueller and Robert M. Cohen: Pharmacologie modelling of Alzheimer's disease. Prog. Neuro-Psychopharmacol. and Biol. Psychiat. 1986, 10 (3–5): 599–610. 1. 1. Evidence pointing to the central role of the cholinergic system in normal human memory function and disorders such as Alzheiner's disease has grown tremendously in recent years. 2. 2. Anticholinergic and non-cholinergic agents have been found to create transient, memory impairments in young adults which mimic the changes asociated with normal aging or amnesia. 3. 3. The rationale for using scopolamine, a centrally active anticholinergic agent, as a pharmacologie probe of memory function is reviewed using data from studies in animals and humans. 4. 4. The cognitive functioning of normal elderly controls given scopolamine is compared to the baseline functioning of patients with Alzheiner's disease, followed by a discussion of the use of scopolamine as a modelling agent for dementia.
登录
查看更多内容
影响因子:
6.1
作者:
Mohs,RC;Davis,KL
通讯作者:
Davis,KL
影响因子:
6.1
作者:
Mohs,RC;Davis,KL;Levy,MI
通讯作者:
Levy,MI
DOI:
10.1176/ajp.139.11.1421
发表时间:
1982-11
期刊:
The American journal of psychiatry
影响因子:
--
作者:
K. Davis;R. Mohs
通讯作者:
K. Davis;R. Mohs
DOI:
--
发表时间:
1983
期刊:
Mayo Clinic proceedings. Mayo Clinic
影响因子:
--
作者:
Richelson,E
通讯作者:
Richelson,E
影响因子:
10.6
作者:
Callaway,E
通讯作者:
Callaway,E